Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Ishimura

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
International Journal of Hematology|December 28, 2024
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemiaKatsuhide Eguchi, Masataka Ishimura, Shouichi Ohga, et al.
Journal of Human Immunity|June 25, 2026
Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trialToshinao Kawai, Mayumi Sako, Katsuhiro Arai, et al.
Clinical and Experimental Immunology|June 25, 2024
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndromeKentaro Nakashima, Takashi Imai, Akira Shiraishi, et al.
Journal of Clinical Immunology|November 30, 2016
A CD57<sup>+</sup> CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 PatientsMasayuki Hori, Takahiro Yasumi, Saeko Shimodera, et al.
The Journal of Infection|August 8, 2016
A nationwide survey of common viral infections in childhood among patients with primary immunodeficiency diseasesEtsuro Nanishi, Takayuki Hoshina, Hidetoshi Takada, et al.
Immunotherapy Advances|March 21, 2024
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label studyHirokazu Kanegane, Akifumi Endo, Satoshi Okada, et al.
Frontiers in Pediatrics|February 20, 2019
Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic <i>IL2RG</i> MutationKay Tanita, Akihiro Hoshino, Ken-Ichi Imadome, et al.
Frontiers in Immunology|March 14, 2022
Case Report: Rotavirus Vaccination and Severe Combined Immunodeficiency in JapanKay Tanita, Yoshiki Kawamura, Hiroki Miura, et al.
European Journal of Medical Genetics|November 7, 2025
Persistent lymphopenia in a Japanese boy with neuronal ceroid lipofuscinosis type 3Kenta Kajiwara, Qiaowei Liang, Yuri Uchiyama, et al.
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|December 28, 2024
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemiaKatsuhide Eguchi, Masataka Ishimura, Shouichi Ohga, et al.
Journal of Human Immunity|June 25, 2026
Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trialToshinao Kawai, Mayumi Sako, Katsuhiro Arai, et al.
Clinical and Experimental Immunology|June 25, 2024
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndromeKentaro Nakashima, Takashi Imai, Akira Shiraishi, et al.
Journal of Clinical Immunology|November 30, 2016
A CD57<sup>+</sup> CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 PatientsMasayuki Hori, Takahiro Yasumi, Saeko Shimodera, et al.
The Journal of Infection|August 8, 2016
A nationwide survey of common viral infections in childhood among patients with primary immunodeficiency diseasesEtsuro Nanishi, Takayuki Hoshina, Hidetoshi Takada, et al.
Immunotherapy Advances|March 21, 2024
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label studyHirokazu Kanegane, Akifumi Endo, Satoshi Okada, et al.
Frontiers in Pediatrics|February 20, 2019
Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic <i>IL2RG</i> MutationKay Tanita, Akihiro Hoshino, Ken-Ichi Imadome, et al.
Frontiers in Immunology|March 14, 2022
Case Report: Rotavirus Vaccination and Severe Combined Immunodeficiency in JapanKay Tanita, Yoshiki Kawamura, Hiroki Miura, et al.
European Journal of Medical Genetics|November 7, 2025
Persistent lymphopenia in a Japanese boy with neuronal ceroid lipofuscinosis type 3Kenta Kajiwara, Qiaowei Liang, Yuri Uchiyama, et al.
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Pageof 12